Urinary Catheter Market

Urinary Catheter Market Outlook (2024 to 2034)

Revenue from the global urinary catheter market size is set to reach US$ 1.89 billion in 2024 and further rise at 3.6% CAGR to climb to US$ 2.68 billion by the end of 2034.

Urinary catheters are used to drain urine from the bladder. Plastic, rubber, and silicone urine catheters are a few types of urinary catheters, based on material. A few of the key variables that are contributing to market growth include the rising prevalence of urological disorders such as urine retention, benign prostatic hyperplasia, cystitis, urinary incontinence, and kidney stones that cause bladder dysfunction. Demand for urinary catheters is projected to increase as more patients with urinary dysfunctions need catheterization for the management and drainage of urine.

Key Market Growth Drivers

• Urinary catheterization is gaining importance with the increasing prevalence of chronic ailments such as diabetes, Parkinson's disease, multiple sclerosis, and spinal cord injuries, all of which can lead to bladder dysfunction requiring intermittent or continuous catheterization.
• A significant ongoing trend in the urinary catheter market, fueling sales, is the innovation in design and materials, aimed at enhancing patient comfort while reducing the risk of infections.
• Technological advancements like intermittent catheters, hydrophilic catheters, and catheters with antimicrobial coatings are enhancing the quality of life for patients reliant on catheterization.
• In post-operative care, particularly in procedures affecting the prostate, bladder, and lower abdomen, urinary catheters are commonly used to manage urinary retention and ensure accurate urine output monitoring.
• With a surge in surgical procedures globally, there is a heightened demand for catheters.
• Demand for urinary catheters that are user-friendly and manageable by patients or caregivers at home is on the rise, driven by the increasing trend of home healthcare. This shift is particularly crucial for individuals requiring long-term care and catheterization.
• The increasing elderly population is driving the expansion of the urinary catheter market size, given prevalent conditions like benign prostatic hyperplasia (BPH), urine incontinence, and other urological issues among them.

Report Attribute	Detail
Urinary Catheter Market Size (2024E)	US$ 1.89 Billion
Forecasted Market Value (2034F)	US$ 2.68 Billion
Global Market Growth Rate (2024 to 2034)	3.6% CAGR
North America Market Share (2024E)	40.3%
East Asia Market Value (2024E)	US$ 400 Million
Sales of Intermittent Catheters (2034F)	US$ 1.59 Billion
Prostate Gland Surgery Segment Value (2034F)	US$ 1.03 Billion
Key Companies Profiled	AngioDynamics Inc.; B. Braun Melsungen AG; Boston Scientific Corporation; Coloplast Group; ConvaTec Group Plc; Cook Medical Inc.; Fresenius Medical Care AG & Co. KGaA; Hollister Inc.; Medline Industries Inc.; Medtronic Plc.; Teleflex Inc.; Wellspect HealthCare.

How Do Urinary Catheters Contribute to Postoperative and Chronic Care?

“Crucial Role of Urinary Catheters in Maintaining Bladder Function After Surgeries”

The market for urinary catheters is significantly being driven by increasing demand for post-surgical applications. After surgeries involving the prostate, bladder, or lower abdomen, urinary catheters are essential for managing urinary retention and accurately measuring urine output. These catheters help prevent complications and promote recovery by maintaining bladder function during the critical postoperative period. The increasing number of surgical procedures globally due to advancements in medical technology and greater healthcare access is driving product demand.

“Easy Usability of Urinary Catheters in Home Settings for Long-Term Catheterization Management”

Growing demand for home healthcare is influencing the urinary catheter market growth as this shift is driven by patients' preference for more comfortable, private, and cost-effective treatment options. Consequently, there is a rising need for user-friendly urinary catheters designed for home use. Chronic care patients, in particular, benefit from these home-use catheters, as they often require long-term catheterization. This trend not only enhances patient convenience and quality of life but also eases the burden on healthcare facilities by enabling patients to manage their conditions in a home setting.

Which Factor is Hurting the Profits of Urinary Catheter Manufacturers?

“Risk of Infections Associated with Central Venous Catheters and High Servicing Costs”

Central venous catheters carry the potential danger of bloodstream infections as they are inserted into large central veins for various medical procedures. Serious problems, extended hospital stays, higher medical costs, and even death are possible outcomes of these infections. Antibiotic-resistant organisms make preventing and treating bloodstream infections linked to central venous catheters more difficult. Multidrug-resistant organisms have emerged partly due to the overuse and misuse of antibiotics. This increases the difficulty of controlling infections.

Sometimes, the limited efficacy of antibiotics against particular organisms leads to treatment failures due to bloodstream infections associated with central lines (CLABSIs). High servicing costs and sporadic product recalls are two factors that are expected to negatively impact the market growth rate and profits of manufacturers.

Country-wise Insights

The North American region is projected to lead with 40.3% of the global urinary catheter market share in 2024, driven by the advanced healthcare infrastructure available in various countries. Western and Eastern Europe are also forecasted to hold a significant market share by 2034 due to supportive government healthcare policies and an increasing number of urinary incontinence cases.

Why Do Urinary Catheter Manufacturers Prioritize the United States as a Key Market?

“Advanced Healthcare Infrastructure and Increasing Demand for Home Healthcare Products”

Attribute	United States
Market Value (2024E)	US$ 684 Million
Growth Rate (2024 to 2034)	4% CAGR
Projected Value (2034F)	US$ 1.01 Billion

The United States is poised to hold a 90.2% market share in North America in 2024. Sales of urinary catheters are increasing in the United States due to several factors such as the rising prevalence of bladder cancer & urinary incontinence, and the rapidly growing rate of the aging population.

Manufacturers from several countries are focusing on the United States market due to its well-developed and advanced healthcare infrastructure. Also, in the country, the market for health products is expanding because of the high demand for intermittent and antimicrobial-coated catheters, as well as the strong emphasis on home healthcare and strict reimbursement guidelines.

How Does the Focus of Japan on Urinary Catheter Innovation Benefit Patients?

“Patients Benefitting from Improved Comfort and Safety”

Attribute	Japan
Market Value (2024E)	US$ 119 Million
Growth Rate (2024 to 2034)	3.4% CAGR
Projected Value (2034F)	US$ 166 Million

Japan holds a significant East Asia market share because of its advanced healthcare structure and a large aging population. The technological advancements in the healthcare sector are the primary factors that are boosting the demand for urinary catheters in the country.

The country is well-known for medical technologies and for creating advanced technical products to improve patient care. These developments include hydrophilic catheters, which lower friction and improve comfort during insertion and use, and antimicrobial-coated catheters, which aid in the prevention of infections. Technological advancements have led to increased adoption and use of urinary catheters to improve patient safety and comfort.

Category-wise Insights

Based on gender, the market is segmented into men and women. Demand for urinary catheters is rising in the male category due to the increasing prevalence of benign prostatic hyperplasia and urine incontinence worldwide.

How Do Intermittent Urinary Catheters Benefit Patients with Spinal Cord Injuries?

“Intermittent Urinary Catheters Reducing Risk of Complications Such as UTIs”

Attribute	Intermittent Catheters
Segment Value (2024E)	US$ 1.08 Billion
Growth Rate (2024 to 2034)	3.9% CAGR
Projected Value (2034F)	US$ 1.59 Billion

Urinary catheters are classified into intermittent catheters, foley/indwelling catheters, and external catheters. Global demand for intermittent catheters is projected to increase at a CAGR of 3.9% through 2034. An intermittent catheter is a medical tool used to drain the bladder. The best method for patients with spinal cord injuries and neurogenic bladder issues to empty their bladders is intermittent urinary catheterization. In contrast to indwelling catheters, which often cause UTIs, these items are favored.

How are Urinary Catheters Contributing to the Recovery of Patients After Prostate Gland Surgery?

“Urinary Catheters Enabling Continuous Urine Output Monitoring”

Attribute	Prostate Gland Surgery
Segment Value (2024E)	US$ 718.3 Billion
Growth Rate (2024 to 2034)	3.7% CAGR
Projected Value (2034F)	US$ 1.03 Billion

Urinary catheters are widely utilized in prostate gland surgery to track urine production and assist in managing post-operative urinary retention. After surgery, the patient finds it difficult to pass urine regularly due to obstructions caused by the prostate gland in the urethra. Healthcare professionals ensure adequate urine drainage from the bladder to lower the risk of issues such as bladder distention and urinary retention by utilizing a urinary catheter. A catheter also makes it possible to continuously monitor urine output, which is crucial for evaluating kidney function and the whole recuperation after surgery, due to this the application of urinary catheters is increasing in prostate gland surgery.

Competitive Landscape

To enhance their market share, key players in the urinary catheter market constantly introduce new devices and broaden their reach by moving farther afield. Additionally, the majority of catheter producers team up with significant medical device distributors to sell and distribute their goods internationally or in certain countries. As a result, makers and distributors of medical devices are forming strategic collaborations. These partnerships not only help producers get a license to sell their products, but they also lessen their liability in the event of product recalls and unfavorable outcomes.

• In April 2024, to assist in preventing catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD), Medline and Consure Medical announced a new arrangement for Medline to offer the QiVi MEC male external urine management device exclusively.
• In April 2024, for the Cymactive 2.0R urinary catheter, which treats males with non-neurogenic chronic urine retention, Ingenion Medical Ltd. was granted a CE mark. According to Ingenion Medical CEO Edward Cappabianca, the technology–which mimics normal urination–will "transform" the lives of men who are now having difficulty utilizing Foley-type catheters. This was reported by BioWorld.
• In December 2023, Bright Uro raised US$ 23 million in Series A funding for assistance in getting FDA approval for its urodynamics system and launching the product in the United States. According to the company’s CEO, if the system is approved, it will be the first product available that can monitor urodynamics wirelessly and without the need for a catheter.
• In July 2023, the company that makes a range of gel-based medicines for the treatment of urological problems, Palette Life Sciences, was acquired by Teleflex. The US$ 600 million upfront payment is part of the vascular device manufacturer's aspirations to treat more reproductive and urinary tract health issues with Palette's portfolio.
• In November 2021, the FDA granted The Flume Catheter Company Ltd. (TFCC) approval to market its catheters in the United States. The company is a medical device business committed to creating a better substitute for the Foley indwelling urinary catheter.

Fact.MR provides detailed information about the price points of key manufacturers of urinary catheters positioned across the world, sales growth, production capacity, and speculative technological expansion, in this updated market report.

Segmentation of Urinary Catheter Market Research

• By Product :

  • Intermittent Catheters
  • Foley/Indwelling Catheters
  • External Catheters

• By Type :

  • Coated Catheters
  • Uncoated Catheters

• By Application :

  • Urinary Incontinence
  • Urinary Retention
  • Benign Prostatic Hyperplasia (BPH)/Prostrate Surgeries
  • Spinal Cord Injuries

• By Gender :

  • Male
  • Female

• By End User :

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa